Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kewaunee Scientific (KEQU) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to 5.86%.

  • Kewaunee Scientific's EBITDA Margin fell 34200.0% to 5.86% in Q4 2025 from the same period last year, while for Oct 2025 it was 6.89%, marking a year-over-year decrease of 13100.0%. This contributed to the annual value of 7.39% for FY2025, which is 15900.0% down from last year.
  • As of Q4 2025, Kewaunee Scientific's EBITDA Margin stood at 5.86%, which was down 34200.0% from 6.76% recorded in Q3 2025.
  • Kewaunee Scientific's 5-year EBITDA Margin high stood at 11.02% for Q2 2025, and its period low was 7.4% during Q4 2021.
  • Over the past 5 years, Kewaunee Scientific's median EBITDA Margin value was 4.76% (recorded in 2023), while the average stood at 3.8%.
  • As far as peak fluctuations go, Kewaunee Scientific's EBITDA Margin tumbled by -73800bps in 2021, and later skyrocketed by 87900bps in 2022.
  • Quarter analysis of 5 years shows Kewaunee Scientific's EBITDA Margin stood at 7.4% in 2021, then surged by 119bps to 1.38% in 2022, then surged by 632bps to 10.13% in 2023, then dropped by -8bps to 9.28% in 2024, then plummeted by -37bps to 5.86% in 2025.
  • Its EBITDA Margin was 5.86% in Q4 2025, compared to 6.76% in Q3 2025 and 11.02% in Q2 2025.